Applied Biosystems has been put at a big disadvantage in an important sequencing patent issue after a key licensing partner was recently named the junior party in a patent interference review triggered by the allowance of an Enzo Biochem patent on DNA sequencing technology.
 
According to a patent attorney with experience in the interference review process, statistics show that companies named a junior party have little chance of winning the US patent office’s designation as original inventor.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.